The Pediatric Blood and Marrow Transplant (BMT) Program at Johns Hopkins All Children’s Hospital is the largest in Florida, and the only pediatric affiliate of Tampa’s H. Lee Moffitt Cancer Center & Research Institute.
Our program was one of the first pediatric centers in the United States to offer “reduced intensity” transplants in an effort to minimize the toxic effects of radiation and chemotherapy. We have developed or are participating in a number of national protocols that utilize hematopoietic stem cell transplantation (HSCT), also known as bone marrow transplantation
, giving our patients access to national and international protocols through our membership in the National Marrow Donor Program, the Pediatric Blood and Marrow Transplant Consortium, the Children’s Oncology Group and the Center for International Blood and Marrow Transplant Research. Our program provides the full range of blood and marrow transplant services, including marrow transplants, peripheral blood stem cell transplants and cord blood transplants.
Affiliation with H. Lee Moffitt Cancer Center
Johns Hopkins All Children’s is the only pediatric affiliate of the H. Lee Moffitt Cancer Center & Research Institute, a National Cancer Institute designated Comprehensive Cancer Center that U.S. News & World Report ranked among the ten best cancer centers in the nation. This formal collaboration lets us provide new and innovative therapies for our patients. Physicians and researchers at Johns Hopkins All Children’s and Moffitt are working together on trials of new medications and therapies, and on research that takes new knowledge about the molecular biology and biochemistry of cancer cells, and their response to potential therapies, from the lab bench to the bedside as soon as possible. One example of this is our new post-transplant tumor vaccine trial.
Our program was founded in 1985 by Robert Good, M.D., Ph.D. A pioneer in the fields of transplantation and immunology, Dr. Good performed the first successful bone marrow transplant in 1967 at the University of Minnesota. Since that first procedure, more than 100,000 blood and marrow transplants have been performed worldwide, and promising new methods of stem cell transplantation are being developed in collaboration with our partners at Moffitt.